Milodistim

Drug Profile

Milodistim

Alternative Names: GM-CSF/IL-3; PIXY 321; Pixykine; Plasmid Immunex yeast 321

Latest Information Update: 23 Nov 1998

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amgen
  • Class Colony-stimulating factors
  • Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Interleukin 3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Chemotherapy-induced damage; Neutropenia; Thrombocytopenia

Most Recent Events

  • 23 Nov 1998 A clinical study has been added to the Haematological disorders therapeutic trials and pharmacokinetics sections
  • 29 Nov 1996 A study has been added to the Haematological disorders therapeutic trials and adverse effects sections
  • 11 Jul 1996 A clinical study has been added to the Cancer therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top